Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies.

Li, Qi; Chen, Zeyuan; Zhou, Xiaoshi; Li, Guolin; Zhang, Changji; Yang, Yong

Li, Qi; Chen, Zeyuan; Zhou, Xiaoshi; Li, Guolin; Zhang, Changji; Yang, Yong.

Afiliación

Li Q; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Chen Z; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhou X; Department of Pharmacy, Luxian People's Hospital, Luzhou, China.
Li G; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhang C; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Yang Y; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Front Genet ; 14: 1187985, 2023.

Article en En | MEDLINE | ID: mdl-37303950

Palabras clave

COVID-19; GPX4; ROS; ferroptosis; inhibitors; iron; multi-organ complications

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Genet Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google